US study of 936 essential workers: 3 doses of mRNA COVID vaccine linked to 24% lower risk of long COVID symptoms after mild cases, especially for neurological and gastrointestinal issues.
I’m open-sourcing a multi-agent Long COVID project from my Master’s Program at UT Austin to explore the disease’s mechanisms, suggest interventions, and test combination treatments.
🧬 MENSA tech uses new antibodies to detect ongoing COVID-19 & viral reactivations in #LongCOVID. With 60% accuracy for SCV2, EBV, CMV, HSV2, it offers diagnostics from a single blood sample.
Differentiates between infection and vaccination responses.